Live from the NIH registry
Studies recruiting near Nashville right now
Top 25 of 1,344 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Nashville, Tennessee (0.4 mi)
· Sponsor: Medtronic
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Vanderbilt University Medical Center Henry-Joyce Cancer Clinic (Adults and Pediatrics) — Nashville, Tennessee (0.4 mi)
· Sponsor: Pierre Fabre Medicament
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Vanderbilt University Medical Center — Nashville, Tennessee (0.4 mi)
· Sponsor: Syndax Pharmaceuticals
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Ascension Saint Thomas — Nashville, Tennessee (0.4 mi)
· Sponsor: Abbott Medical Devices
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Sarah Cannon Research Institute — Nashville, Tennessee (0.4 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
The Children's Hospital at TriStar Centennial — Nashville, Tennessee (0.4 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Associates, P. C. — Nashville, Tennessee (0.4 mi)
· Sponsor: Pacific Edge Limited
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
Sarah Cannon Research Institute (SCRI) Oncology Partners — Nashville, Tennessee (0.4 mi)
· Sponsor: Acepodia Biotech, Inc.
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Sarah Cannon Research Institute (SCRI) Oncology Partners — Nashville, Tennessee (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository
Clonal Hematopoiesis
N/A
Observational 800 participants sought
Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee (0.4 mi)
· Sponsor: Vanderbilt-Ingram Cancer Center
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
Duchenne Muscular Dystrophy (DMD)
Phase 1
Interventional 10 participants sought
Vanderbilt University Medical Center — Nashville, Tennessee (0.4 mi)
· Sponsor: Vanderbilt University Medical Center
Suction vs Underwater Seal for HemoPneumoThoraX Trial
Hemothorax; Traumatic, Hemopneumothorax; Traumatic
N/A
Interventional 150 participants sought
Vanderbilt University Medical Center — Nashville, Tennessee (0.4 mi)
· Sponsor: Vanderbilt University Medical Center
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Tennessee Retina — Nashville, Tennessee (0.4 mi)
· Sponsor: Boehringer Ingelheim
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Sarah Cannon Research Institute — Nashville, Tennessee (0.4 mi)
· Sponsor: Immuneering Corporation
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
HIV
Phase 1
Interventional 54 participants sought
Vanderbilt Vaccine (VV) CRS Site# 30352 — Nashville, Tennessee (0.4 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit
N/A
Interventional 108 participants sought
Vanderbilt University — Nashville, Tennessee (0.4 mi)
· Sponsor: Edwards Lifesciences
Angelman Syndrome Natural History Study
Angelman Syndrome
N/A
Observational 300 participants sought
Monroe Carell Jr. Children's Hospital at Vanderbilt — Nashville, Tennessee (0.4 mi)
· Sponsor: Boston Children's Hospital
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
Vanderbilt University Medical Center — Nashville, Tennessee (0.4 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Tennessee Retina PC — Nashville, Tennessee (0.4 mi)
· Sponsor: Genentech, Inc.
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
Vanderbilt University Medical Center — Nashville, Tennessee (0.4 mi)
· Sponsor: Allogene Therapeutics
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Nashville, Tennessee (0.4 mi)
· Sponsor: Sameek Roychowdhury
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Nashville, TN — Nashville, Tennessee (0.4 mi)
· Sponsor: Mediar Therapeutics
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Nashville, Tennessee (0.4 mi)
· Sponsor: Daiichi Sankyo
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Sarah Cannon Research Institute SCRI — Nashville, Tennessee (0.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
SCRI Oncology Partners — Nashville, Tennessee (0.4 mi)
· Sponsor: Lyell Immunopharma, Inc.